Healthcare

Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...

Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...

Novo Nordisk’s shares staged a dramatic recovery on Friday, surging nearly 7% to close at €35.16, as investors seized on...

The irony could hardly be starker. As Siemens Healthineers kicks off the ECIO oncology conference in Basel today, showcasing the...

The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...

Siemens Healthineers is charting an ambitious course into artificial intelligence while grappling with a punishing market environment that has driven...

Novo Nordisk closed the week with a 6.4% bounce to €35.09, its best single-day showing in months, after unveiling positive...

Siemens Healthineers shares slumped to a fresh 52-week trough on Friday, touching €35.29, as the medical technology group prepares to...

The narrative around BioNTech is undergoing a quiet but decisive shift. While the Mainz-based biotech’s legacy COVID-19 vaccine business sputters,...

The Danish drugmaker is fighting on multiple fronts — and losing ground on most of them. While Novo Nordisk celebrates...